Your Article Summary
BTG Sells HySolv Technology to Major Pharmaceutical Company
BTG, 08/31/09
BTG plc , the specialty pharmaceuticals company, announces the sale of its HySolv drug delivery technology to Novartis Pharma AG for an initial payment of US$0.75m and potential additional future milestone payments of up to US$9.25m. Under the terms of the agreement, Novartis acquires all of the patent rights and know how with respect to the HySolv drug delivery technology.
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Mediware Makes Two Buys
HealthDataManagement, 12/10/09
Visanne cleared for market launch in Europe as new treatment option for endometriosis
BayNews International, 12/08/09
Bristol-Myers Squibb and Mead Johnson Announce Amendment and Extension of Exchange Offer
Bristol Myers-Squibb Company, 12/07/09
Article Search
Sponsor


See Latest Articles


